1 Study Coverage 1.1 Solid Tumor Drug Product Introduction 1.2 Market by Type 1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Small Molecules 1.2.3 Biologics 1.3 Market by Application 1.3.1 Global Solid Tumor Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Oncology 1.3.3 Neurology 1.3.4 Radiology 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Solid Tumor Drug Sales Estimates and Forecasts 2017-2028 2.2 Global Solid Tumor Drug Revenue Estimates and Forecasts 2017-2028 2.3 Global Solid Tumor Drug Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Solid Tumor Drug Sales by Region 2.4.1 Global Solid Tumor Drug Sales by Region (2017-2022) 2.4.2 Global Sales Solid Tumor Drug by Region (2023-2028) 2.5 Global Solid Tumor Drug Revenue by Region 2.5.1 Global Solid Tumor Drug Revenue by Region (2017-2022) 2.5.2 Global Solid Tumor Drug Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Solid Tumor Drug Sales by Manufacturers 3.1.1 Global Top Solid Tumor Drug Manufacturers by Sales (2017-2022) 3.1.2 Global Solid Tumor Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Solid Tumor Drug in 2021 3.2 Global Solid Tumor Drug Revenue by Manufacturers 3.2.1 Global Solid Tumor Drug Revenue by Manufacturers (2017-2022) 3.2.2 Global Solid Tumor Drug Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Solid Tumor Drug Revenue in 2021 3.3 Global Solid Tumor Drug Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Solid Tumor Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Solid Tumor Drug Sales by Type 4.1.1 Global Solid Tumor Drug Historical Sales by Type (2017-2022) 4.1.2 Global Solid Tumor Drug Forecasted Sales by Type (2023-2028) 4.1.3 Global Solid Tumor Drug Sales Market Share by Type (2017-2028) 4.2 Global Solid Tumor Drug Revenue by Type 4.2.1 Global Solid Tumor Drug Historical Revenue by Type (2017-2022) 4.2.2 Global Solid Tumor Drug Forecasted Revenue by Type (2023-2028) 4.2.3 Global Solid Tumor Drug Revenue Market Share by Type (2017-2028) 4.3 Global Solid Tumor Drug Price by Type 4.3.1 Global Solid Tumor Drug Price by Type (2017-2022) 4.3.2 Global Solid Tumor Drug Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Solid Tumor Drug Sales by Application 5.1.1 Global Solid Tumor Drug Historical Sales by Application (2017-2022) 5.1.2 Global Solid Tumor Drug Forecasted Sales by Application (2023-2028) 5.1.3 Global Solid Tumor Drug Sales Market Share by Application (2017-2028) 5.2 Global Solid Tumor Drug Revenue by Application 5.2.1 Global Solid Tumor Drug Historical Revenue by Application (2017-2022) 5.2.2 Global Solid Tumor Drug Forecasted Revenue by Application (2023-2028) 5.2.3 Global Solid Tumor Drug Revenue Market Share by Application (2017-2028) 5.3 Global Solid Tumor Drug Price by Application 5.3.1 Global Solid Tumor Drug Price by Application (2017-2022) 5.3.2 Global Solid Tumor Drug Price Forecast by Application (2023-2028) 6 North America 6.1 North America Solid Tumor Drug Market Size by Type 6.1.1 North America Solid Tumor Drug Sales by Type (2017-2028) 6.1.2 North America Solid Tumor Drug Revenue by Type (2017-2028) 6.2 North America Solid Tumor Drug Market Size by Application 6.2.1 North America Solid Tumor Drug Sales by Application (2017-2028) 6.2.2 North America Solid Tumor Drug Revenue by Application (2017-2028) 6.3 North America Solid Tumor Drug Market Size by Country 6.3.1 North America Solid Tumor Drug Sales by Country (2017-2028) 6.3.2 North America Solid Tumor Drug Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Solid Tumor Drug Market Size by Type 7.1.1 Europe Solid Tumor Drug Sales by Type (2017-2028) 7.1.2 Europe Solid Tumor Drug Revenue by Type (2017-2028) 7.2 Europe Solid Tumor Drug Market Size by Application 7.2.1 Europe Solid Tumor Drug Sales by Application (2017-2028) 7.2.2 Europe Solid Tumor Drug Revenue by Application (2017-2028) 7.3 Europe Solid Tumor Drug Market Size by Country 7.3.1 Europe Solid Tumor Drug Sales by Country (2017-2028) 7.3.2 Europe Solid Tumor Drug Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Solid Tumor Drug Market Size by Type 8.1.1 Asia Pacific Solid Tumor Drug Sales by Type (2017-2028) 8.1.2 Asia Pacific Solid Tumor Drug Revenue by Type (2017-2028) 8.2 Asia Pacific Solid Tumor Drug Market Size by Application 8.2.1 Asia Pacific Solid Tumor Drug Sales by Application (2017-2028) 8.2.2 Asia Pacific Solid Tumor Drug Revenue by Application (2017-2028) 8.3 Asia Pacific Solid Tumor Drug Market Size by Region 8.3.1 Asia Pacific Solid Tumor Drug Sales by Region (2017-2028) 8.3.2 Asia Pacific Solid Tumor Drug Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Solid Tumor Drug Market Size by Type 9.1.1 Latin America Solid Tumor Drug Sales by Type (2017-2028) 9.1.2 Latin America Solid Tumor Drug Revenue by Type (2017-2028) 9.2 Latin America Solid Tumor Drug Market Size by Application 9.2.1 Latin America Solid Tumor Drug Sales by Application (2017-2028) 9.2.2 Latin America Solid Tumor Drug Revenue by Application (2017-2028) 9.3 Latin America Solid Tumor Drug Market Size by Country 9.3.1 Latin America Solid Tumor Drug Sales by Country (2017-2028) 9.3.2 Latin America Solid Tumor Drug Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Solid Tumor Drug Market Size by Type 10.1.1 Middle East and Africa Solid Tumor Drug Sales by Type (2017-2028) 10.1.2 Middle East and Africa Solid Tumor Drug Revenue by Type (2017-2028) 10.2 Middle East and Africa Solid Tumor Drug Market Size by Application 10.2.1 Middle East and Africa Solid Tumor Drug Sales by Application (2017-2028) 10.2.2 Middle East and Africa Solid Tumor Drug Revenue by Application (2017-2028) 10.3 Middle East and Africa Solid Tumor Drug Market Size by Country 10.3.1 Middle East and Africa Solid Tumor Drug Sales by Country (2017-2028) 10.3.2 Middle East and Africa Solid Tumor Drug Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Corporation Information 11.1.2 AstraZeneca Overview 11.1.3 AstraZeneca Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 AstraZeneca Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 AstraZeneca Recent Developments 11.2 Biogen 11.2.1 Biogen Corporation Information 11.2.2 Biogen Overview 11.2.3 Biogen Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Biogen Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Biogen Recent Developments 11.3 Baxter 11.3.1 Baxter Corporation Information 11.3.2 Baxter Overview 11.3.3 Baxter Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Baxter Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Baxter Recent Developments 11.4 Celgene Corporation 11.4.1 Celgene Corporation Corporation Information 11.4.2 Celgene Corporation Overview 11.4.3 Celgene Corporation Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Celgene Corporation Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Celgene Corporation Recent Developments 11.5 Abbott Laboratories 11.5.1 Abbott Laboratories Corporation Information 11.5.2 Abbott Laboratories Overview 11.5.3 Abbott Laboratories Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Abbott Laboratories Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Abbott Laboratories Recent Developments 11.6 Pfizer Inc 11.6.1 Pfizer Inc Corporation Information 11.6.2 Pfizer Inc Overview 11.6.3 Pfizer Inc Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Pfizer Inc Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Pfizer Inc Recent Developments 11.7 Amgen Limited & Amgen Ireland Limited 11.7.1 Amgen Limited & Amgen Ireland Limited Corporation Information 11.7.2 Amgen Limited & Amgen Ireland Limited Overview 11.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Amgen Limited & Amgen Ireland Limited Recent Developments 11.8 Bristol-Myers Squibb Company 11.8.1 Bristol-Myers Squibb Company Corporation Information 11.8.2 Bristol-Myers Squibb Company Overview 11.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Bristol-Myers Squibb Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Bristol-Myers Squibb Company Recent Developments 11.9 GlaxoSmithKline plc. 11.9.1 GlaxoSmithKline plc. Corporation Information 11.9.2 GlaxoSmithKline plc. Overview 11.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 GlaxoSmithKline plc. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 GlaxoSmithKline plc. Recent Developments 11.10 F. Hoffmann-La Roche Ltd. 11.10.1 F. Hoffmann-La Roche Ltd. Corporation Information 11.10.2 F. Hoffmann-La Roche Ltd. Overview 11.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 F. Hoffmann-La Roche Ltd. Recent Developments 11.11 Eli Lilly and Company 11.11.1 Eli Lilly and Company Corporation Information 11.11.2 Eli Lilly and Company Overview 11.11.3 Eli Lilly and Company Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Eli Lilly and Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Eli Lilly and Company Recent Developments 11.12 Johnson & Johnson 11.12.1 Johnson & Johnson Corporation Information 11.12.2 Johnson & Johnson Overview 11.12.3 Johnson & Johnson Solid Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Johnson & Johnson Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Johnson & Johnson Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Solid Tumor Drug Industry Chain Analysis 12.2 Solid Tumor Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Solid Tumor Drug Production Mode & Process 12.4 Solid Tumor Drug Sales and Marketing 12.4.1 Solid Tumor Drug Sales Channels 12.4.2 Solid Tumor Drug Distributors 12.5 Solid Tumor Drug Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Solid Tumor Drug Industry Trends 13.2 Solid Tumor Drug Market Drivers 13.3 Solid Tumor Drug Market Challenges 13.4 Solid Tumor Drug Market Restraints 14 Key Findings in The Global Solid Tumor Drug Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Solid Tumor Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Small Molecules Table 3. Major Manufacturers of Biologics Table 4. Global Solid Tumor Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Solid Tumor Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Solid Tumor Drug Sales by Region (2017-2022) & (K MT) Table 7. Global Solid Tumor Drug Sales Market Share by Region (2017-2022) Table 8. Global Solid Tumor Drug Sales by Region (2023-2028) & (K MT) Table 9. Global Solid Tumor Drug Sales Market Share by Region (2023-2028) Table 10. Global Solid Tumor Drug Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Solid Tumor Drug Revenue Market Share by Region (2017-2022) Table 12. Global Solid Tumor Drug Revenue by Region (2023-2028) & (US$ Million) Table 13. Global Solid Tumor Drug Revenue Market Share by Region (2023-2028) Table 14. Global Solid Tumor Drug Sales by Manufacturers (2017-2022) & (K MT) Table 15. Global Solid Tumor Drug Sales Share by Manufacturers (2017-2022) Table 16. Global Solid Tumor Drug Revenue by Manufacturers (2017-2022) & (US$ Million) Table 17. Global Solid Tumor Drug Revenue Share by Manufacturers (2017-2022) Table 18. Solid Tumor Drug Price by Manufacturers (2017-2022) &(USD/MT) Table 19. Global Solid Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Solid Tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2021) Table 21. Solid Tumor Drug Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Solid Tumor Drug Product Offered Table 23. Date of Manufacturers Enter into Solid Tumor Drug Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Solid Tumor Drug Sales by Type (2017-2022) & (K MT) Table 26. Global Solid Tumor Drug Sales by Type (2023-2028) & (K MT) Table 27. Global Solid Tumor Drug Sales Share by Type (2017-2022) Table 28. Global Solid Tumor Drug Sales Share by Type (2023-2028) Table 29. Global Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million) Table 30. Global Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million) Table 31. Global Solid Tumor Drug Revenue Share by Type (2017-2022) Table 32. Global Solid Tumor Drug Revenue Share by Type (2023-2028) Table 33. Solid Tumor Drug Price by Type (2017-2022) & (USD/MT) Table 34. Global Solid Tumor Drug Price Forecast by Type (2023-2028) & (USD/MT) Table 35. Global Solid Tumor Drug Sales by Application (2017-2022) & (K MT) Table 36. Global Solid Tumor Drug Sales by Application (2023-2028) & (K MT) Table 37. Global Solid Tumor Drug Sales Share by Application (2017-2022) Table 38. Global Solid Tumor Drug Sales Share by Application (2023-2028) Table 39. Global Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million) Table 40. Global Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million) Table 41. Global Solid Tumor Drug Revenue Share by Application (2017-2022) Table 42. Global Solid Tumor Drug Revenue Share by Application (2023-2028) Table 43. Solid Tumor Drug Price by Application (2017-2022) & (USD/MT) Table 44. Global Solid Tumor Drug Price Forecast by Application (2023-2028) & (USD/MT) Table 45. North America Solid Tumor Drug Sales by Type (2017-2022) & (K MT) Table 46. North America Solid Tumor Drug Sales by Type (2023-2028) & (K MT) Table 47. North America Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million) Table 48. North America Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million) Table 49. North America Solid Tumor Drug Sales by Application (2017-2022) & (K MT) Table 50. North America Solid Tumor Drug Sales by Application (2023-2028) & (K MT) Table 51. North America Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million) Table 52. North America Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million) Table 53. North America Solid Tumor Drug Sales by Country (2017-2022) & (K MT) Table 54. North America Solid Tumor Drug Sales by Country (2023-2028) & (K MT) Table 55. North America Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million) Table 56. North America Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million) Table 57. Europe Solid Tumor Drug Sales by Type (2017-2022) & (K MT) Table 58. Europe Solid Tumor Drug Sales by Type (2023-2028) & (K MT) Table 59. Europe Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million) Table 60. Europe Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million) Table 61. Europe Solid Tumor Drug Sales by Application (2017-2022) & (K MT) Table 62. Europe Solid Tumor Drug Sales by Application (2023-2028) & (K MT) Table 63. Europe Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million) Table 64. Europe Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million) Table 65. Europe Solid Tumor Drug Sales by Country (2017-2022) & (K MT) Table 66. Europe Solid Tumor Drug Sales by Country (2023-2028) & (K MT) Table 67. Europe Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million) Table 68. Europe Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million) Table 69. Asia Pacific Solid Tumor Drug Sales by Type (2017-2022) & (K MT) Table 70. Asia Pacific Solid Tumor Drug Sales by Type (2023-2028) & (K MT) Table 71. Asia Pacific Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million) Table 72. Asia Pacific Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million) Table 73. Asia Pacific Solid Tumor Drug Sales by Application (2017-2022) & (K MT) Table 74. Asia Pacific Solid Tumor Drug Sales by Application (2023-2028) & (K MT) Table 75. Asia Pacific Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million) Table 76. Asia Pacific Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million) Table 77. Asia Pacific Solid Tumor Drug Sales by Region (2017-2022) & (K MT) Table 78. Asia Pacific Solid Tumor Drug Sales by Region (2023-2028) & (K MT) Table 79. Asia Pacific Solid Tumor Drug Revenue by Region (2017-2022) & (US$ Million) Table 80. Asia Pacific Solid Tumor Drug Revenue by Region (2023-2028) & (US$ Million) Table 81. Latin America Solid Tumor Drug Sales by Type (2017-2022) & (K MT) Table 82. Latin America Solid Tumor Drug Sales by Type (2023-2028) & (K MT) Table 83. Latin America Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million) Table 84. Latin America Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million) Table 85. Latin America Solid Tumor Drug Sales by Application (2017-2022) & (K MT) Table 86. Latin America Solid Tumor Drug Sales by Application (2023-2028) & (K MT) Table 87. Latin America Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million) Table 88. Latin America Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million) Table 89. Latin America Solid Tumor Drug Sales by Country (2017-2022) & (K MT) Table 90. Latin America Solid Tumor Drug Sales by Country (2023-2028) & (K MT) Table 91. Latin America Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million) Table 92. Latin America Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million) Table 93. Middle East and Africa Solid Tumor Drug Sales by Type (2017-2022) & (K MT) Table 94. Middle East and Africa Solid Tumor Drug Sales by Type (2023-2028) & (K MT) Table 95. Middle East and Africa Solid Tumor Drug Revenue by Type (2017-2022) & (US$ Million) Table 96. Middle East and Africa Solid Tumor Drug Revenue by Type (2023-2028) & (US$ Million) Table 97. Middle East and Africa Solid Tumor Drug Sales by Application (2017-2022) & (K MT) Table 98. Middle East and Africa Solid Tumor Drug Sales by Application (2023-2028) & (K MT) Table 99. Middle East and Africa Solid Tumor Drug Revenue by Application (2017-2022) & (US$ Million) Table 100. Middle East and Africa Solid Tumor Drug Revenue by Application (2023-2028) & (US$ Million) Table 101. Middle East and Africa Solid Tumor Drug Sales by Country (2017-2022) & (K MT) Table 102. Middle East and Africa Solid Tumor Drug Sales by Country (2023-2028) & (K MT) Table 103. Middle East and Africa Solid Tumor Drug Revenue by Country (2017-2022) & (US$ Million) Table 104. Middle East and Africa Solid Tumor Drug Revenue by Country (2023-2028) & (US$ Million) Table 105. AstraZeneca Corporation Information Table 106. AstraZeneca Description and Major Businesses Table 107. AstraZeneca Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 108. AstraZeneca Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 109. AstraZeneca Recent Developments Table 110. Biogen Corporation Information Table 111. Biogen Description and Major Businesses Table 112. Biogen Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 113. Biogen Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 114. Biogen Recent Developments Table 115. Baxter Corporation Information Table 116. Baxter Description and Major Businesses Table 117. Baxter Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 118. Baxter Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 119. Baxter Recent Developments Table 120. Celgene Corporation Corporation Information Table 121. Celgene Corporation Description and Major Businesses Table 122. Celgene Corporation Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 123. Celgene Corporation Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 124. Celgene Corporation Recent Developments Table 125. Abbott Laboratories Corporation Information Table 126. Abbott Laboratories Description and Major Businesses Table 127. Abbott Laboratories Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 128. Abbott Laboratories Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 129. Abbott Laboratories Recent Developments Table 130. Pfizer Inc Corporation Information Table 131. Pfizer Inc Description and Major Businesses Table 132. Pfizer Inc Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 133. Pfizer Inc Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 134. Pfizer Inc Recent Developments Table 135. Amgen Limited & Amgen Ireland Limited Corporation Information Table 136. Amgen Limited & Amgen Ireland Limited Description and Major Businesses Table 137. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 138. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 139. Amgen Limited & Amgen Ireland Limited Recent Developments Table 140. Bristol-Myers Squibb Company Corporation Information Table 141. Bristol-Myers Squibb Company Description and Major Businesses Table 142. Bristol-Myers Squibb Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 143. Bristol-Myers Squibb Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 144. Bristol-Myers Squibb Company Recent Developments Table 145. GlaxoSmithKline plc. Corporation Information Table 146. GlaxoSmithKline plc. Description and Major Businesses Table 147. GlaxoSmithKline plc. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 148. GlaxoSmithKline plc. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 149. GlaxoSmithKline plc. Recent Developments Table 150. F. Hoffmann-La Roche Ltd. Corporation Information Table 151. F. Hoffmann-La Roche Ltd. Description and Major Businesses Table 152. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 153. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 154. F. Hoffmann-La Roche Ltd. Recent Developments Table 155. Eli Lilly and Company Corporation Information Table 156. Eli Lilly and Company Description and Major Businesses Table 157. Eli Lilly and Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 158. Eli Lilly and Company Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 159. Eli Lilly and Company Recent Developments Table 160. Johnson & Johnson Corporation Information Table 161. Johnson & Johnson Description and Major Businesses Table 162. Johnson & Johnson Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 163. Johnson & Johnson Solid Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 164. Johnson & Johnson Recent Developments Table 165. Key Raw Materials Lists Table 166. Raw Materials Key Suppliers Lists Table 167. Solid Tumor Drug Distributors List Table 168. Solid Tumor Drug Customers List Table 169. Solid Tumor Drug Market Trends Table 170. Solid Tumor Drug Market Drivers Table 171. Solid Tumor Drug Market Challenges Table 172. Solid Tumor Drug Market Restraints Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Solid Tumor Drug Product Picture Figure 3. Global Solid Tumor Drug Market Share by Type in 2021 & 2028 Figure 3. Small Molecules Product Picture Figure 4. Biologics Product Picture Figure 5. Global Solid Tumor Drug Market Share by Application in 2021 & 2028 Figure 6. Oncology Figure 7. Neurology Figure 8. Radiology Figure 9. Others Figure 10. Solid Tumor Drug Report Years Considered Figure 11. Global Solid Tumor Drug Sales 2017-2028 (K MT) Figure 12. Global Solid Tumor Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Solid Tumor Drug Revenue 2017-2028 (US$ Million) Figure 14. Global Solid Tumor Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 15. Global Solid Tumor Drug Sales Market Share by Region (2017-2022) Figure 16. Global Solid Tumor Drug Sales Market Share by Region (2023-2028) Figure 17. North America Solid Tumor Drug Sales YoY (2017-2028) & (K MT) Figure 18. North America Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million) Figure 19. Europe Solid Tumor Drug Sales YoY (2017-2028) & (K MT) Figure 20. Europe Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million) Figure 21. Asia-Pacific Solid Tumor Drug Sales YoY (2017-2028) & (K MT) Figure 22. Asia-Pacific Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million) Figure 23. Latin America Solid Tumor Drug Sales YoY (2017-2028) & (K MT) Figure 24. Latin America Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million) Figure 25. Middle East & Africa Solid Tumor Drug Sales YoY (2017-2028) & (K MT) Figure 26. Middle East & Africa Solid Tumor Drug Revenue YoY (2017-2028) & (US$ Million) Figure 27. The Solid Tumor Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 28. The Top 5 and 10 Largest Manufacturers of Solid Tumor Drug in the World: Market Share by Solid Tumor Drug Revenue in 2021 Figure 29. Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 30. Global Solid Tumor Drug Sales Market Share by Type (2017-2028) Figure 31. Global Solid Tumor Drug Revenue Market Share by Type (2017-2028) Figure 32. Global Solid Tumor Drug Sales Market Share by Application (2017-2028) Figure 33. Global Solid Tumor Drug Revenue Market Share by Application (2017-2028) Figure 34. North America Solid Tumor Drug Sales Market Share by Type (2017-2028) Figure 35. North America Solid Tumor Drug Revenue Market Share by Type (2017-2028) Figure 36. North America Solid Tumor Drug Sales Market Share by Application (2017-2028) Figure 37. North America Solid Tumor Drug Revenue Market Share by Application (2017-2028) Figure 38. North America Solid Tumor Drug Sales Share by Country (2017-2028) Figure 39. North America Solid Tumor Drug Revenue Share by Country (2017-2028) Figure 40. U.S. Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 41. Canada Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 42. Europe Solid Tumor Drug Sales Market Share by Type (2017-2028) Figure 43. Europe Solid Tumor Drug Revenue Market Share by Type (2017-2028) Figure 44. Europe Solid Tumor Drug Sales Market Share by Application (2017-2028) Figure 45. Europe Solid Tumor Drug Revenue Market Share by Application (2017-2028) Figure 46. Europe Solid Tumor Drug Sales Share by Country (2017-2028) Figure 47. Europe Solid Tumor Drug Revenue Share by Country (2017-2028) Figure 48. Germany Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 49. France Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 50. U.K. Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 51. Italy Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 52. Russia Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 53. Asia Pacific Solid Tumor Drug Sales Market Share by Type (2017-2028) Figure 54. Asia Pacific Solid Tumor Drug Revenue Market Share by Type (2017-2028) Figure 55. Asia Pacific Solid Tumor Drug Sales Market Share by Application (2017-2028) Figure 56. Asia Pacific Solid Tumor Drug Revenue Market Share by Application (2017-2028) Figure 57. Asia Pacific Solid Tumor Drug Sales Share by Region (2017-2028) Figure 58. Asia Pacific Solid Tumor Drug Revenue Share by Region (2017-2028) Figure 59. China Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 60. Japan Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 61. South Korea Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 62. India Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 63. Australia Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 64. China Taiwan Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 65. Indonesia Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 66. Thailand Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 67. Malaysia Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 68. Latin America Solid Tumor Drug Sales Market Share by Type (2017-2028) Figure 69. Latin America Solid Tumor Drug Revenue Market Share by Type (2017-2028) Figure 70. Latin America Solid Tumor Drug Sales Market Share by Application (2017-2028) Figure 71. Latin America Solid Tumor Drug Revenue Market Share by Application (2017-2028) Figure 72. Latin America Solid Tumor Drug Sales Share by Country (2017-2028) Figure 73. Latin America Solid Tumor Drug Revenue Share by Country (2017-2028) Figure 74. Mexico Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 75. Brazil Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 76. Argentina Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 77. Middle East and Africa Solid Tumor Drug Sales Market Share by Type (2017-2028) Figure 78. Middle East and Africa Solid Tumor Drug Revenue Market Share by Type (2017-2028) Figure 79. Middle East and Africa Solid Tumor Drug Sales Market Share by Application (2017-2028) Figure 80. Middle East and Africa Solid Tumor Drug Revenue Market Share by Application (2017-2028) Figure 81. Middle East and Africa Solid Tumor Drug Sales Share by Country (2017-2028) Figure 82. Middle East and Africa Solid Tumor Drug Revenue Share by Country (2017-2028) Figure 83. Turkey Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 84. Saudi Arabia Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 85. UAE Solid Tumor Drug Revenue (2017-2028) & (US$ Million) Figure 86. Solid Tumor Drug Value Chain Figure 87. Solid Tumor Drug Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

AstraZeneca Biogen Baxter Celgene Corporation Abbott Laboratories Pfizer Inc Amgen Limited & Amgen Ireland Limited Bristol-Myers Squibb Company GlaxoSmithKline plc. F. Hoffmann-La Roche Ltd. Eli Lilly and Company Johnson & Johnson